9: Pharmacokinetics of Naproxen Sodium

Abstract

Get full access to this article

View all access options for this article.

References

Segre

. Naproxen sodium (Anaprox). J Reprod Med 1980;25:222–5.

Sevelius

Segre

Bursick

. Bioavailability of naproxen sodium and its relationship to clinical analgesic effects. Br J Clin Pharmacol 1980;10:259–63.

Runkel

Kraft

Boost

. Naproxen oral absorption characteristics. Chem Pharm Bull 1972;20:1457–66.

Runkel

Chaplin

Boost

. Absorption, distribution, metabolism, and excretion of naproxen in various laboratory animals and human subjects. J Pharm Sci 1972;61:703–8.

Runkel

Forchielli

Boost

. Naproxen—metabolism, excretion and comparative pharmacokinetics. Scand J Rheumatol 1973;Suppl 2:29–36.

Levy

. Pharmacokinetics of salicylate elimination in man. J Pharm Sci 1965;54:959–67.

Murthy

DVK

Kruseman-Aretz

. Inhibition of prostaglandin (PG) synthase by 6,11-dihydrodibenzo-[be]-thiepin-11-one-3-acetic acid (DBTA), a novel nonsteroidal anti-inflammatory agent (NSAA). Fed Proc 1978;37:662.

Upton

Williams

Kelly

. Naproxen pharmacokinetics in the elderly. Br J Clin Pharmacol 1984;18:207.